SecBot SecBot
SECBOTREPLAY Home › Report › NUVL

NUVL · GSK plc has completed its acquisition of Nuvalent, Inc

Nuvalent, Inc. · 8-K filed Jul 15, 2026 at 09:03 ET

At the news

BULLISHIMPACT 5/10

8-K filed Jul 15, 2026 at 09:03 ET

GSK plc has completed its acquisition of Nuvalent, Inc. via a tender offer and merger. The tender offer expired with 91.3% of shares tendered, and the merger closed on July 15, 2026, at $124.00 per share in cash, representing a total equity value of approximately $10.6 billion. All outstanding shares, options, and RSUs were cashed out, and the company will be delisted from Nasdaq.

  • Tender offer expired on July 14, 2026 with 72,518,967 shares (91.3% of outstanding) validly tendered
  • Merger closed on July 15, 2026 under DGCL Section 251(h) without a stockholder vote
  • Shareholders received $124.00 per share in cash, less applicable withholding
  • Total equity value of the transaction approximately $10.6 billion

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access